Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Treating babies who have sickle cell disease (SCD) with oral liquid hydroxyurea appears to prevent the onset of long-term complications triggered by this disease, according to results of a preliminary study by investigators at St. Jude Children's Research Hospital.

16 Jun 2005

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

15 Jun 2005

Blood abnormality, sickle cell trait, gives added protection to children from malaria

The blood cell abnormality, sickle cell trait, gives an increasing amount of protection against malaria as young children grow during their first ten years of life, new research has revealed.

30 May 2005

Researchers have identified a new clinical syndrome

Researchers have identified a new clinical syndrome that produces serious and sometimes fatal symptoms in a variety of seemingly unrelated diseases. The syndrome, described in the April 6 issue of the Journal of the American Medical Association, is caused by hemolysis, the destruction of red blood cells.

5 Apr 2005

Method of gene therapy accurately corrects mutations in disease-causing genes

Harnessing the strength of a natural process that repairs damage to the human genome, a researcher from UT Southwestern Medical Center has helped establish a method of gene therapy that can accurately and permanently correct mutations in disease-causing genes.

5 Apr 2005

Method of gene therapy that can accurately and permanently correct mutations in disease-causing genes

4 Apr 2005

Beginning of new wave - first generation to turn 18 since technology and treatments have allowed them to survive to adulthood

More than half a million children with special health-care needs will turn 18 this year, the first generation to reach adulthood since sweeping medical advances ensured an unprecedented number would survive congenital conditions that until recently would have killed them.

27 Feb 2005

New bone marrow model could help people with sickle cell disease

A new model showing how sickle cell blood cells operate within bone marrow is presented at a conference in Austria today. Researchers at Imperial College London, who developed the model, hope that it will eventually be used by clinicians to advance more effective treatments for sickle cell disease.

20 Feb 2005

Level of immune cell DNA in the blood might help predict success of stem cell transplantation

Measuring the quantity of a certain type of immune cell DNA in the blood could help physicians predict whether a bone marrow stem cell transplant will successfully restore a population of infection-fighting cells called T lymphocytes in a child.

7 Feb 2005

New understanding of the causes for symptoms of sickle cell disease

A new understanding of the causes for symptoms of sickle cell disease, a condition affecting one in every 600 African-Americans, has resulted from a study by researchers at Duke University Medical Center and Howard Hughes Medical Institute (HHMI). Their findings may lead to a new, more direct method for treating the disease, they said.

31 Jan 2005

New advances in sickle cell disease

Excruciating pain episodes, recurrent pneumonias, strokes, severe infections, chronic hemolytic anemia, and secondary pulmonary hypertension are common complications of sickle cell disease, a life-threatening inherited defect in blood that causes normally disc-shaped red blood cells to take on a sickle shape.

6 Dec 2004

Children with sickle cell disease who are at risk for a stroke need ongoing blood transfusions to reduce their risk

“This important study shows the value of continuing periodic blood transfusions in preventing the serious and debilitating consequences of stroke,” says NHLBI Acting Director Barbara Alving. “At the same time, there are risks of chronic transfusions and the decision to continue with this treatment must be made on a case-by-case basis.”

6 Dec 2004

Californians say yes on 71

With a clear mandate, the voters of California yesterday overwhelmingly approved Proposition 71, the California Stem Cell Research and Cures Initiative.

4 Nov 2004

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer--as well as among their parents.

28 Oct 2004

New research points to potential new treatments for sickle cell disease

New research from the University of North Carolina at Chapel Hill reveals why red blood cells from people with sickle cell disease are stickier than healthy red cells, pointing the way to potential new treatments for sickle cell disease.

12 Oct 2004

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Indiana State health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine to immunizing people at high risk from complications of influenza.

6 Oct 2004

Vanilla may become a drug to treat sickle cell disease

In addition to its popular role in flavoring ice cream, fudge and cake frosting, vanilla may have a future use as a medicine. Recent laboratory research has strengthened the possibility that a form of vanilla may become a drug to treat sickle cell disease.

20 Sep 2004

California Chamber of Commerce lends support to stem cell research

The California Chamber of Commerce has joined with a broad and growing coalition of business groups, patient advocates and medical organizations in endorsing a "YES" vote on Proposition 71, the California Stem Cell Research and Cures Initiative, on the November 2004 statewide ballot.

14 Sep 2004

Potential new drug for the treatment of sickle cell disease

The results were published in the June 2004 issue of The British Journal of Haematology (BJH). MX-1520 is a prodrug of vanillin, a very popular food additive generally regarded as safe (GRAS) by the FDA.

13 Sep 2004

Medicinal qualities of plants shown to ease symptoms of genetic disease

Phytomedicines are medicines derived from plants and often responsible for the healing effects of traditional remedies used.

21 Jul 2004

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Hydroxyurea may prevent complications such as organ damage and stunted growth in treatment of sickle cell disease

Oral liquid Hydroxyurea promising for long-term use in babies with sickle cell disease

Blood abnormality, sickle cell trait, gives added protection to children from malaria

Researchers have identified a new clinical syndrome

Method of gene therapy accurately corrects mutations in disease-causing genes

Method of gene therapy that can accurately and permanently correct mutations in disease-causing genes

Beginning of new wave - first generation to turn 18 since technology and treatments have allowed them to survive to adulthood

New bone marrow model could help people with sickle cell disease

Level of immune cell DNA in the blood might help predict success of stem cell transplantation

New understanding of the causes for symptoms of sickle cell disease

New advances in sickle cell disease

Children with sickle cell disease who are at risk for a stroke need ongoing blood transfusions to reduce their risk

Californians say yes on 71

Brief psychological interventions are effective in relieving traumatic stress symptoms in family members

New research points to potential new treatments for sickle cell disease

Indiana health officials are appealing to health care providers to limit use of this year’s diminished supply of flu vaccine

Vanilla may become a drug to treat sickle cell disease

California Chamber of Commerce lends support to stem cell research

Potential new drug for the treatment of sickle cell disease

Medicinal qualities of plants shown to ease symptoms of genetic disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in